Triple
T7156988
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Exicure, Inc. |
E166837
|
entity |
| Predicate | abbreviation |
P43
|
FINISHED |
| Object |
Exicure
Exicure is a biotechnology company focused on developing nucleic acid therapeutics using its proprietary spherical nucleic acid (SNA) technology platform.
|
E645747
|
NE FINISHED |
Provenance (5 batches)
| Stage | Batch ID | Job type | Status |
|---|---|---|---|
| creating | batch_69c68887a5cc8190bec0ea96227164f7 |
elicitation | completed |
| NER | batch_69c6e80f14808190907ee84523630d85 |
ner | completed |
| NED1 | batch_69c7adb530388190b68fa05418d3e184 |
ned_source_triple | completed |
| NED2 | batch_69c7af1133b08190a32dccf82015c19e |
ned_description | completed |
| NEDg | batch_69c7ae830c74819091d6d65ac6fba32b |
nedg | completed |
Created at: March 27, 2026, 2:47 p.m.